Collects device data during heart pressure tests in adults with heart conditions
Collects HemoCept device data from people having right heart catheterization for heart conditions.
Plain-language title generated from the registry record
Registry title: Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Key facts
- Where
- Boulder, United StatesSee the site
Where in United States
- Boulder HeartBoulder, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- HemoCept Inc.
- Trial code
- NCT07224906
- Record updated
- 13 April 2026
- Original description
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.Read full original descriptionShow less
Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Inclusion: Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures; Subjects can be any gender but must be age 18 or older; Subject is able and willing to provide informed consent and HIPAA authorization; Subject is able and willing to meet all study requirements; Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible).
Exclusion: Subject is pregnant, breastfeeding, or intends to become pregnant during this study.